|
Magnesium sulfate Clinical Trials
4 actively recruiting trials across 3 locations
No change since May 2026
Also known as: Epsom Salt, Magnesium Sulphate 15% Solution, MgSO₄
Pipeline
Phase 1: 1Phase 2: 2Phase 3: 1
Top Sponsors
- Suzanne Schuh1
- NYU Langone Health1
- M.D. Anderson Cancer Center1
- Brigham and Women's Hospital1
Indications
- Cancer2
- Return of Spontaneous Circulation1
- Heart Disease1
- Cardiac Arrest1
- Asthma1
Other1 trial
Boston, Massachusetts1 trial
MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
Brigham and Women's Hospital
Phase 2
New York, New York1 trial
Post-CA Neuroprotection With Magnesium
NYU Langone Health
Phase 1
Houston, Texas1 trial
Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
The University of Texas M. D. Anderson Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.